Comparative Analysis of the Relationship Between Trichloroethylene Metabolism and Tissue-Specific Toxicity Among Inbred Mouse Strains: Liver Effects

REFERENCES

• Agency for Toxic Substances and Disease Registry. 2013. Priority list of hazardous substances, October 25, 2011. http://www.atsdr.cdc.gov/SPL/index.html (accessed July 26, 2013).
   Google Scholar
• Anna, C. H., R. R. Maronpot, M. A. Pereira, J. F. Foley, D. E. Malarkey, and M. W. Anderson. 1994. Ras proto-oncogene activation in dichloroacetic acid-, trichloroethylene- and tetrachloroethylene-induced liver tumors in B6C3F1 mice. Carcinogenesis 15: 2255–2261.
   PubMed Web of Science ®Google Scholar
• Austin, E. W., J. M. Parrish, D. H. Kinder, and R. J. Bull. 1996. Lipid peroxidation and formation of 8-hydroxydeoxyguanosine from acute doses of halogenated acetic acids. Fundam. Appl. Toxicol. 31: 77–82.
   PubMedGoogle Scholar
• Bradford, B. U., E. F. Lock, O. Kosyk, S. Kim, T. Uehara, D. Harbourt, M. DeSimone, D. W. Threadgill, V. Tryndyak, I. P. Pogribny, L. Bleyle, D. R. Koop, and I. Rusyn. 2011. Interstrain differences in the liver effects of trichloroethylene in a multi-strain panel of inbred mice. Toxicol. Sci. 120: 206–217.
   PubMed Web of Science ®Google Scholar
• Chaudhry, A. S., T. J. Urban, J. K. Lamba, A. K. Birnbaum, R. P. Remmel, M. Subramanian, S. Strom, J. H. You, D. Kasperaviciute, C. B. Catarino, R. A. Radtke, S. M. Sisodiya, D. B. Goldstein, and E. G. Schuetz. 2010. CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose. J. Pharmacol. Exp. Ther. 332: 599–611.
   PubMed Web of Science ®Google Scholar
• Chiu, W. A., J. L. Campbell, H. J. Clewell, Y. H. Zhou, F. A. Wright, K. Z. Guyton, and I. Rusyn. 2014. Physiologically-based pharmacokinetic (PBPK) modeling of inter-strain variability in trichloroethylene metabolism in the mouse. Environ. Health Perspect. 122: 456–463.
   PubMed Web of Science ®Google Scholar
• Chiu, W. A., J. Jinot, C. S. Scott, S. L. Makris, G. S. Cooper, R. C. Dzubow, A. S. Bale, M. V. Evans, K. Z. Guyton, N. Keshava, J. C. Lipscomb, S. Barone, J. F. Fox, M. R. Gwinn, J. Schaum, and J. C. Caldwell. 2013. Human health effects of trichloroethylene: Key findings and scientific issues. Environ. Health Perspect. 121: 303–311.
   PubMed Web of Science ®Google Scholar
• Chiu, W. A., M. S. Okino, and M. V. Evans. 2009. Characterizing uncertainty and population variability in the toxicokinetics of trichloroethylene and metabolites in mice, rats, and humans using an updated database, physiologically based pharmacokinetic (PBPK) model, and Bayesian approach. Toxicol. Appl. Pharmacol. 241: 36–60.
   PubMed Web of Science ®Google Scholar
• Corton, J. C. 2008. Evaluation of the role of peroxisome proliferator-activated receptor alpha (PPARalpha) in mouse liver tumor induction by trichloroethylene and metabolites. Crit Rev Toxicol 38: 857–875.
   PubMed Web of Science ®Google Scholar
• Dekant, W., A. Schulz, M. Metzler, and D. Henschler. 1986. Absorption, elimination and metabolism of trichloroethylene: a quantitative comparison between rats and mice. Xenobiotica 16: 143–152.
   PubMed Web of Science ®Google Scholar
• Green, T. 1990. Species differences in carcinogenicity: The role of metabolism in human risk evaluation. Teratogen. Carcinogen. Mutagen. 10: 103–113.
   PubMedGoogle Scholar
• Green, T., and M. S. Prout. 1985. Species differences in response to trichloroethylene. II. Biotransformation in rats and mice. Toxicol. Appl. Pharmacol. 79: 401–411.
   PubMed Web of Science ®Google Scholar
• Guha, N., D. Loomis, Y. Grosse, B. Lauby-Secretan, F. El Ghissassi, V. Bouvard, L. Benbrahim-Tallaa, R. Baan, H. Mattock, K. Straif, and International Agency for Research on Cancer Monograph Working Group. 2012. Carcinogenicity of trichloroethylene, tetrachloroethylene, some other chlorinated solvents, and their metabolites. Lancet Oncol. 13: 1192–1193.
   PubMed Web of Science ®Google Scholar
• Hansen, J., M. Sallmen, A. I. Selden, A. Anttila, E. Pukkala, K. Andersson, I. L. Bryngelsson, O. Raaschou-Nielsen, J. H. Olsen, and J. K. McLaughlin. 2013. Risk of cancer among workers exposed to trichloroethylene: Analysis of three nordic cohort studies. J. Natl. Cancer Inst. 105: 869–877.
   PubMed Web of Science ®Google Scholar
• Keshava, N., and J. C. Caldwell. 2006. Key issues in the role of peroxisome proliferator-activated receptor agonism and cell signaling in trichloroethylene toxicity. Environ. Health Perspect. 114: 1464–1470.
   PubMed Web of Science ®Google Scholar
• Ketcha, M. M., D. K. Stevens, D. A. Warren, C. T. Bishop, and W. T. Brashear. 1996. Conversion of trichloroacetic acid to dichloroacetic acid in biological samples. J. Anal. Toxicol. 20: 236–241.
   PubMed Web of Science ®Google Scholar
• Kim, S., L. B. Collins, G. Boysen, J. A. Swenberg, A. Gold, L. M. Ball, B. U. Bradford, and I. Rusyn. 2009a. Liquid chromatography electrospray ionization tandem mass spectrometry analysis method for simultaneous detection of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine. Toxicology 262: 230–238.
   PubMed Web of Science ®Google Scholar
• Kim, S., D. Kim, G. M. Pollack, L. B. Collins, and I. Rusyn. 2009b. Pharmacokinetic analysis of trichloroethylene metabolism in male B6C3F1 mice: Formation and disposition of trichloroacetic acid, dichloroacetic acid, S-(1,2-dichlorovinyl)glutathione and S-(1,2-dichlorovinyl)-L-cysteine. Toxicol. Appl. Pharmacol. 238: 90–99.
   PubMed Web of Science ®Google Scholar
• Klaunig, J. E., M. A. Babich, K. P. Baetcke, J. C. Cook, J. C. Corton, R. M. David, J. G. Deluca, D. Y. Lai, R. H. McKee, J. M. Peters, R. A. Roberts, and P. A. Fenner-Crisp. 2003. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol. 33: 655–780.
   PubMed Web of Science ®Google Scholar
• Lash, L. H., W. A. Chiu, K. Z. Guyton, and I. Rusyn. 2014. Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity. Mutat. Res., in press. DOI:10.1016/j.mrrev.2014.04.003
   Google Scholar
• Lash, L. H., D. A. Putt, W. T. Brashear, R. Abbas, J. C. Parker, and J. W. Fisher. 1999. Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene. J. Toxicol. Environ. Health A 56: 1–21.
   PubMed Web of Science ®Google Scholar
• Lash, L. H., D. A. Putt, and J. C. Parker. 2006. Metabolism and tissue distribution of orally administered trichloroethylene in male and female rats: Identification of glutathione- and cytochrome P-450-derived metabolites in liver, kidney, blood, and urine. J. Toxicol. Environ. Health A 69: 1285–1309.
   PubMed Web of Science ®Google Scholar
• Lash, L. H., W. Qian, D. A. Putt, S. E. Hueni, A. A. Elfarra, R. J. Krause, and J. C. Parker. 2001. Renal and hepatic toxicity of trichloroethylene and its glutathione-derived metabolites in rats and mice: Sex-, species-, and tissue-dependent differences. J. Pharmacol. Exp. Ther. 297: 155–164.
   PubMed Web of Science ®Google Scholar
• Lipscomb, J. C., D. A. Mahle, W. T. Brashear, and C. M. Garrett. 1996. A species comparison of chloral hydrate metabolism in blood and liver. Biochem. Biophys. Res. Commun. 227: 340–350.
   PubMed Web of Science ®Google Scholar
• Maloney, E. K., and D. J. Waxman. 1999. Trans-activation of PPARalpha and PPARgamma by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161: 209–218.
   PubMed Web of Science ®Google Scholar
• Marsman, D. S., R. C. Cattley, J. G. Conway, and J. A. Popp. 1988. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2- pyrimidinylthio]acetic acid (Wy-14,643) in rats. Cancer Res. 48: 6739–6744.
   PubMed Web of Science ®Google Scholar
• Nakajima, T., R. S. Wang, E. Elovaara, S. S. Park, H. V. Gelboin, and H. Vainio. 1993. Cytochrome P450-related differences between rats and mice in the metabolism of benzene, toluene, and trichloroethylene in liver microsomes. Biochem. Pharmacol. 45: 1079–1085.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program. 1990. Carcinogenesis studies of trichloroethylene (without epichlorohydrin) (CAS no. 79-01-6) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 243: 1–174.
   PubMedGoogle Scholar
• National Industrial Chemicals Notification and Assessment Scheme. 2000. Trichloroethylene: Priority existing chemical assessment report. Australia: National Industrial Chemicals Notification and Assessment Scheme. Sydney, Australia.
   Google Scholar
• National Research Council. 2006. Assessing the human health risks of trichloroethylene: Key scientific issues. Washington, DC: National Academies Press.
   Google Scholar
• Parrish, J. M., E. W. Austin, D. K. Stevens, D. H. Kinder, and R. J. Bull. 1996. Haloacetate-induced oxidative damage to DNA in the liver of male B6C3F1 mice. Toxicology 110: 103–111.
   PubMed Web of Science ®Google Scholar
• Prout, M. S., W. M. Provan, and T. Green. 1985. Species differences in response to trichloroethylene. I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharmacol. 79: 389–400.
   PubMed Web of Science ®Google Scholar
• Radican, L., A. Blair, P. Stewart, and D. Wartenberg. 2008. Mortality of aircraft maintenance workers exposed to trichloroethylene and other hydrocarbons and chemicals: Extended follow-up. J. Occup. Environ. Med. 50: 1306–1319.
   PubMed Web of Science ®Google Scholar
• Rusyn, I., W. A. Chiu, L. H. Lash, H. Kromhout, J. Hansen, and K. Z. Guyton. 2014. Trichloroethylene: Mechanistic, epidemiologic and other supporting evidence of carcinogenic hazard. Pharmacol. Ther. 141: 55–68.
   PubMed Web of Science ®Google Scholar
• Scott, C. S., and J. Jinot. 2011. Trichloroethylene and cancer: Systematic and quantitative review of epidemiologic evidence for identifying hazards. Int. J. Environ. Res. Public Health 8: 4238–4372.
   PubMed Web of Science ®Google Scholar
• Song, J. Z., and J. W. Ho. 2003. Simultaneous detection of trichloroethylene alcohol and acetate in rat urine by gas chromatography–mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 789: 303–309.
   PubMed Web of Science ®Google Scholar
• Stenner, R. D., J. L. Merdink, D. K. Stevens, D. L. Springer, and R. J. Bull. 1997. Enterohepatic recirculation of trichloroethanol glucuronide as a significant source of trichloroacetic acid. Metabolites of trichloroethylene. Drug Metab. Dispos. 25: 529–535.
   PubMed Web of Science ®Google Scholar
• Storey, J. D., and R. Tibshirani. 2003. Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100(16): 9440–9445.
   PubMed Web of Science ®Google Scholar
• U.S. Environmental Protection Agency. 2011. Toxicological review of trichloroethylene (CAS no. 79-01-6): In support of summary information on the Integrated Risk Information System (IRIS). Washington, DC: National Center for Environmental Assessment.
   Google Scholar
• van Bladeren, P. J. 2000. Glutathione conjugation as a bioactivation reaction. Chem. Biol. Interact. 129: 61–76.
   PubMed Web of Science ®Google Scholar
• Vlaanderen, J., K. Straif, E. Pukkala, T. Kauppinen, P. Kyyronen, J. I. Martinsen, K. Kjaerheim, L. Tryggvadottir, J. Hansen, P. Sparen, and E. Weiderpass. 2013. Occupational exposure to trichloroethylene and perchloroethylene and the risk of lymphoma, liver, and kidney cancer in four Nordic countries. Occup. Environ. Med. 70: 393–401.
   PubMed Web of Science ®Google Scholar
• von Grote, J., C. Hurlimann, M. Scheringer, and K. Hungerbuhler. 2003. Reduction of occupational exposure to perchloroethylene and trichloroethylene in metal degreasing over the last 30 years: Influences of technology innovation and legislation. J. Expos. Anal. Environ. Epidemiol. 13: 325–340.
   PubMedGoogle Scholar
• Walgren, J. E., D. T. Kurtz, and J. M. McMillan. 2000. Expression of PPAR(alpha) in human hepatocytes and activation by trichloroacetate and dichloroacetate. Res. Commun. Mol. Pathol. Pharmacol. 108: 116–132.
   PubMed Web of Science ®Google Scholar
• Zeise, L., F. Y. Bois, W. A. Chiu, D. Hattis, I. Rusyn, and K. Z. Guyton. 2013. Addressing human variability in next-generation human health risk assessments of environmental chemicals. Environ. Health Perspect. 121: 23–31.
   PubMed Web of Science ®Google Scholar
• Zhou, Y. C., and D. J. Waxman. 1998. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ. Health Perspect. 106(Suppl. 4): 983–988.
   PubMedGoogle Scholar